Z Squared Inc. also files under ZSQR, BHSE, BHSEU; those filings are included. Filings under COEP by Coeptis Therapeutics Inc. (CIK 0001819663) from Nov 16, 2021 to Nov 16, 2021 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Harris Jeffery Keeslar | Chief Technology Officer | Grant(A) | 50K | — | $0 |
| Aug 18, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Buy(P) | 1K | $3.92 | $4K |
| Jun 3, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 3K | — | $0 |
| Jun 3, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 3K | — | $0 |
| Apr 30, 2026 | BSG Series CM, LLC | 10% Owner | Other(J) | 41.5M | — | $0 |
| Apr 27, 2026 | Sohn Adam Craig | Director | Grant(A) | 10K | — | $0 |
| Apr 27, 2026 | Cooper Kenneth Lyle | Director | Grant(A) | 10K | — | $0 |
| Apr 27, 2026 | Cogley Brian | Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Apr 27, 2026 | Halabu David Elias | Co-Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Apr 27, 2026 | Burke Michelle Ellen | Co-Chief Executive Officer, Director | Grant(A) | 16K | — | $0 |
| Apr 27, 2026 | Fuerst Bryan Eric | Director | Grant(A) | 10K | — | $0 |
| Apr 27, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 10K | — | $0 |
| Apr 27, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 100K | — | $0 |
| Apr 27, 2026 | Cogley Brian | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Apr 27, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 100K | — | $0 |
| Apr 27, 2026 | Schadel Christopher Ryan | Chief Marketing Officer | Grant(A) | 10K | — | $0 |
| Feb 11, 2026 | Cogley Brian | Chief Financial Officer | Grant(A) | 13K | — | $0 |
| Feb 11, 2026 | Cogley Brian | Chief Financial Officer | Option exercise(M) | 10K | $10.56 | $106K |
| Feb 11, 2026 | Sheehy Christine Elise | VP Compliance and Secy | Option exercise(M) | 1K | $10.56 | $11K |
| Feb 11, 2026 | Sheehy Christine Elise | VP Compliance and Secy | Grant(A) | 13K | — | $0 |
| Feb 11, 2026 | Salkind Gene | Director | Option exercise(M) | 6K | $10.56 | $60K |
| Feb 11, 2026 | Salkind Gene | Director | Grant(A) | 3K | — | $0 |
| Feb 11, 2026 | Cochran Christopher P. | Director | Option exercise(M) | 6K | $10.56 | $60K |
| Feb 11, 2026 | Cochran Christopher P. | Director | Grant(A) | 3K | — | $0 |
| Feb 11, 2026 | DeSilva Tara | Director | Option exercise(M) | 6K | $10.56 | $60K |
| Feb 11, 2026 | DeSilva Tara | Director | Grant(A) | 3K | — | $0 |
| Feb 11, 2026 | Yerace Daniel Alexander | VP Operations, Director | Option exercise(M) | 10K | $10.41 | $104K |
| Feb 11, 2026 | Yerace Daniel Alexander | VP Operations, Director | Grant(A) | 20K | — | $0 |
| Feb 11, 2026 | Mehalick David | CEO and President, Director, 10% Owner | Option exercise(M) | 149K | $7.05 | $1.0M |
| Feb 11, 2026 | Mehalick David | CEO and President, Director, 10% Owner | Grant(A) | 51K | — | $0 |
| Feb 11, 2026 | Calise Chris | Director | Option exercise(M) | 6K | $10.56 | $60K |
| Feb 11, 2026 | Calise Chris | Director | Grant(A) | 3K | — | $0 |
| Feb 11, 2026 | Deschamps Philippe | Director | Option exercise(M) | 6K | $10.56 | $60K |
| Feb 11, 2026 | Deschamps Philippe | Director | Grant(A) | 3K | — | $0 |
| Mar 4, 2025 | Deschamps Philippe | Director | Grant(A) | 6K | — | — |
| Mar 4, 2025 | Calise Chris | Director | Grant(A) | 6K | — | — |
| Mar 4, 2025 | Cochran Christopher P. | Director | Grant(A) | 6K | — | — |
| Mar 4, 2025 | DeSilva Tara | Director | Grant(A) | 6K | — | — |
| Mar 4, 2025 | Mehalick David | CEO and President, Director, 10% Owner | Grant(A) | 29K | — | — |
| Mar 4, 2025 | Salkind Gene | Director | Grant(A) | 6K | — | — |
| Mar 4, 2025 | Sheehy Christine Elise | VP Compliance and Secy | Grant(A) | 1K | — | — |
| Mar 4, 2025 | Yerace Daniel Alexander | VP of Operations, Director | Grant(A) | 5K | — | — |
| Mar 4, 2025 | Cogley Brian | Chief Financial Officer | Grant(A) | 10K | — | — |
| Jan 12, 2024 | DeSilva Tara | Director | Buy(P) | 2K | $0.58 | $1K |
| Jan 12, 2024 | DeSilva Tara | Director | Buy(P) | 466 | $0.56 | $261 |
| Jan 10, 2024 | Cogley Brian | Chief Financial Officer | Buy(P) | 5K | $0.67 | $3K |
| Jan 8, 2024 | Mehalick David | CEO and President, Director, 10% Owner | Buy(P) | 14K | $0.66 | $9K |
| Jan 8, 2024 | Mehalick David | CEO and President, Director, 10% Owner | Buy(P) | 6K | $0.67 | $4K |
| Jan 5, 2024 | Yerace Daniel Alexander | VP of Operations, Director | Buy(P) | 11K | $0.69 | $7K |
| Jan 5, 2024 | Cochran Christopher P. | Director | Buy(P) | 7K | $0.77 | $5K |
| Jan 5, 2024 | Mehalick David | CEO and President, Director, 10% Owner | Buy(P) | 5K | $0.69 | $3K |
| Jan 5, 2024 | Salkind Gene | Director | Buy(P) | 12K | $0.69 | $8K |
| Dec 7, 2023 | Mehalick David | CEO and President, Director, 10% Owner | Gift(G) | 700K | — | $0 |
| Aug 29, 2023 | Salkind Gene | Director | Buy(P) | 4K | $1.01 | $4K |
| Aug 25, 2023 | Salkind Gene | Director | Buy(P) | 29K | $0.91 | $26K |
| Aug 23, 2023 | Calise Chris | Director | Buy(P) | 9K | $0.94 | $8K |
| Aug 23, 2023 | Calise Chris | Director | Buy(P) | 3K | $0.94 | $2K |
| Jan 27, 2023 | DeSilva Tara | Director | Grant(A) | 30K | — | — |
| Jan 27, 2023 | Mehalick David | CEO and President, Director, 10% Owner | Grant(A) | 250K | — | — |
| Jan 27, 2023 | Salkind Gene | Director | Grant(A) | 30K | — | — |
| Jan 27, 2023 | Sheehy Christine Elise | CFO and Secretary, Director | Grant(A) | 200K | — | — |
| Jan 27, 2023 | Yerace Daniel Alexander | VP of Operations, Director | Grant(A) | 200K | — | — |
| Jan 27, 2023 | Deschamps Philippe | Director | Grant(A) | 30K | — | — |
| Jan 27, 2023 | Cochran Christopher P. | Director | Grant(A) | 30K | — | — |
| Jan 27, 2023 | Calise Chris | Director | Grant(A) | 30K | — | — |
| Jan 27, 2023 | Mehalick David | CEO and President, Director, 10% Owner | Grant(A) | 375K | — | — |
| Oct 28, 2022 | Calise Chris | Director, 10% Owner | Grant(A) | 3.0M | $1.00 | $3.0M |
| May 4, 2022 | Harraden Circle Investors GP, LP | 10% Owner | Sell(S) | 85K | $10.11 | $862K |
| May 26, 2021 | Glazer Capital, LLC | 10% Owner | Sell(S) | 6K | $9.85 | $60K |
| May 25, 2021 | Glazer Capital, LLC | 10% Owner | Sell(S) | 50K | $9.85 | $493K |
| Dec 14, 2020 | Striar Robert | Chief Executive Officer, Director, 10% Owner | Other(J) | 281K | — | $0 |
| Dec 14, 2020 | Bull Horn Holdings Sponsor LLC | 10% Owner | Other(J) | 281K | — | $0 |
| Dec 14, 2020 | Calise Chris | Chief Financial Officer, Director, 10% Owner | Other(J) | 281K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Z Squared Inc., SEC CIK 0001759186. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under COEP and shows every filing by that issuer (also filed as ZSQR, BHSE, BHSEU). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for COEP